StockpollyBeta
Get App
BTAI · NASDAQ · Biotechnology

BioXcel Therapeutics (BTAI)

Develops neuroscience therapies through a data-driven drug re-innovation model.

$0.0739
0.00 (0.00%)
Delisted · Sep 8, 2026

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions19.73%6.18M shares
48 holders · as of Jun 30, 2026
Insiders0.85%266.3K shares
8 holders · as of Jun 17, 2026
Strategic holders8.29%2.60M shares
3 holders · as of May 15, 2026
Other71.13%22.27M shares
remainder

31.31M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Millennium Management LLCInstitution
6.76%2.11Mas of Jun 30, 2026
Armistice Capital, LLCStrategic
6.10%1.91Mfiled May 15, 2026
Oaktree Capital Management LPInstitution
4.41%1.38Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
2.94%919,545as of Jun 30, 2026
BioXcel LLC1,2Strategic10 percent owner
1.90%594,040filed Sep 28, 2023
Oaktree Fund Advisors, LLCInstitution
0.78%245,585as of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.77%242,251as of Jun 30, 2026
BlackRock, Inc.Institution
0.57%179,433as of Jun 30, 2026
UBS Group AGInstitution
0.50%158,065as of Jun 30, 2026
Citadel Advisors LLCInstitution
0.48%149,220as of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution
0.44%136,937as of Jun 30, 2026
AllianceBernstein L.P.Insider
0.30%94,298filed Feb 14, 2022
State Street CorpInstitution
0.29%92,118as of Jun 30, 2026
BlackRock, Inc.Strategic
0.29%91,433filed Feb 3, 2023
FMR LLCInstitution
0.29%90,300as of Jun 30, 2026
Wiley Bros.-Aintree Capital, LLCInstitution
0.27%83,588as of Jun 30, 2026
Vimal MehtaInsiderdirector, officer: CEO and President
0.22%69,817filed Jun 17, 2026
Jones Financial Companies LLLPInstitution
0.20%63,139as of Jun 30, 2026
Northern Trust CorpInstitution
0.18%56,318as of Jun 30, 2026
Hightower Advisors, LLCInstitution
0.13%41,000as of Jun 30, 2026
Quadrature Capital LtdInstitution
0.12%38,038as of Jun 30, 2026
Javier RodriguezInsiderofficer: See Remarks
0.09%26,838filed Jun 17, 2026
Richard I. SteinhartInsiderofficer: Chief Financial Officer
0.08%26,335filed Jun 17, 2026
Frank YoccaInsiderofficer: Chief Scientific Officer
0.08%26,210filed Jun 17, 2026
Headlands Technologies LLCInstitution
0.08%25,556as of Jun 30, 2026
  1. BioXcel LLC's transaction reports restate only vehicles that traded; the 2023 ownership statement (594.0K) is used instead.
  2. BioXcel LLC reports a block also reported by another filer; it is counted once, under that filer.

13F, as of Jun 30, 2026

48 holders · 6.18M shares · 11 new positions · 23 increased · 8 reduced · 3 closed

HolderShares% outstandingChg q/qFiled
Millennium Management LLC2.11M6.76%+178.0KAug 14, 2026
Oaktree Capital Management LP1.38M4.41%+1.14MAug 14, 2026
Vanguard Capital Management LLC919.5K2.94%+712.2KAug 13, 2026
Oaktree Fund Advisors, LLC245.6K0.78%+202.7KAug 14, 2026
Geode Capital Management, LLC242.3K0.77%+12.1KAug 12, 2026
BlackRock, Inc.179.4K0.57%+95.2KAug 7, 2026
UBS Group AG158.1K0.50%+105.3KAug 13, 2026
Citadel Advisors LLC149.2K0.48%+149.2KnewSep 2, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Integrated Core Strategies (US) LLC8.40%1.83M13GFeb 9, 2026
Armistice Capital, LLC7.05%1.91M13GMay 15, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
May 20, 2026
Vimal Mehtadirector, officer: CEO and President
Sale19,419$1.0969,598
May 20, 2026
Richard I. Steinhartofficer: Chief Financial Officer
Sale6,845$1.0926,300
May 20, 2026
Javier Rodriguezofficer: See Remarks
Sale6,560$1.0826,803
May 20, 2026
Frank Yoccaofficer: Chief Scientific Officer
Sale6,845$1.0926,175

House and Senate disclosures

Not reported.